Alvotech ALVO
NASDAQ ALVO
$5.62 -0.18 (-3.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alvotech (ALVO) Income - Equity (2021 - 2023)

Updated

Alvotech (ALVO) posted Income - Equity of -$3.17 million for Q4 2023, compared with -$858,000 a year earlier.

Analysis

Alvotech (ALVO) Income - Equity (2021 - 2023) Analysis & Trends

For FY2023, Alvotech's Income - Equity came in at -$7.15 million.

  • In prior years, Alvotech's Income - Equity was -$2.59 million in FY2022, -$2.42 million in FY2021, -$1.51 million in FY2020 and -$192,000 in FY2019.
  • Quarterly Income - Equity has run from a low of -$7.15 million in Q1 2023 to a high of $1.32 million in Q2 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income - Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alvotech 1.81 Bn 1.37 Bn 2.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.17 Mn
Sep 30, 2023 -1.28 Mn
Jun 30, 2023 -1.54 Mn
Mar 20, 2023 -7.15 Mn
Dec 31, 2022 -858,000.00
Sep 30, 2022 -466,000.00
Jun 30, 2022 1.32 Mn
Mar 20, 2022 -2.59 Mn
Dec 31, 2021 -2.42 Mn
Sep 30, 2021 -837,000.00
API Access

Alvotech Income - Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-equity&ticker=ALVO&period=max&api_key=YOUR_API_KEY